| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |